20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Amphastar Pharmaceuticals, Inc. - (AMPH) operates in the NASDAQ industry and is headquartered in Rancho Cucamonga, United States with about 1,976 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, AMPH reported $720M in revenue and $98M in net income.
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.
Interactive charts & full statements → Open the AMPH valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $730M | $720M | $732M | $644M | $499M | $438M | $350M | $322M | $295M | $240M | $255M | $252M | $210M | $230M | $204M | $118M |
| Gross Profit | $348M | $356M | $374M | $351M | $249M | $200M | $143M | $132M | $107M | $91M | $104M | $77M | $51M | $87M | $90M | $28M |
| Gross Margin % | 47.7% | 49.5% | 51.1% | 54.5% | 49.9% | 45.6% | 41.0% | 40.9% | 36.3% | 37.8% | 40.8% | 30.8% | 24.3% | 37.9% | 44.2% | 23.8% |
| Operating Income (EBIT) | $114M | $140M | $205M | $197M | $107M | $70M | $11M | $0M | ($9M) | ($1M) | $16M | ($7M) | ($18M) | $17M | $25M | ($34M) |
| Operating Margin % | 15.7% | 19.5% | 28.1% | 30.6% | 21.5% | 16.0% | 3.1% | -0.0% | -2.9% | -0.4% | 6.2% | -2.7% | -8.5% | 7.6% | 12.4% | -28.3% |
| Net Income | $79M | $98M | $160M | $138M | $91M | $62M | $1M | $49M | ($6M) | $5M | $11M | ($3M) | ($11M) | $12M | $18M | $8M |
| Net Margin % | 10.8% | 13.6% | 21.8% | 21.3% | 18.3% | 14.2% | 0.4% | 15.2% | -1.9% | 1.9% | 4.1% | -1.1% | -5.1% | 5.2% | 8.9% | 6.6% |
| EBITDA | $175M | $212M | $277M | $240M | $146M | $112M | $30M | $21M | $8M | $12M | $30M | $4M | ($3M) | $31M | $38M | ($20M) |
| Earnings Per Share (EPS) | $1.71 | $2.03 | $3.06 | $2.60 | $1.74 | $1.25 | $0.03 | $0.98 | $-0.12 | $0.09 | $0.22 | $-0.06 | $-0.25 | $1.48 | $2.26 | $0.97 |
| Shares Outstanding (M) | 44M | 48M | 52M | 53M | 52M | 50M | 49M | 50M | 46M | 48M | 48M | 45M | 42M | 8M | 8M | 8M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $184M | $171M | $183M | $192M | $174M | $171M | $187M | $189M |
| Gross Profit | $93M | $70M | $86M | $99M | $86M | $85M | $87M | $102M |
| Gross Margin % | 50.8% | 41.1% | 46.8% | 51.4% | 49.6% | 50.0% | 46.5% | 54.0% |
| Operating Income (EBIT) | $40M | $14M | $36M | $25M | $42M | $37M | $45M | $57M |
| Operating Margin % | 21.6% | 8.0% | 19.4% | 13.2% | 24.2% | 21.9% | 24.2% | 30.2% |
| Net Income | $30M | $6M | $24M | $17M | $31M | $25M | $38M | $40M |
| Net Margin % | 16.5% | 3.8% | 13.3% | 9.0% | 17.8% | 14.8% | 20.3% | 21.4% |
| EBITDA | $45M | $33M | $55M | $42M | $62M | $52M | $65M | $69M |
| Earnings Per Share (EPS) | $0.69 | $0.14 | $0.52 | $0.36 | $0.64 | $0.51 | $0.73 | $0.78 |
| Shares Outstanding (M) | 44M | 46M | 47M | 48M | 48M | 50M | 52M | 52M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 | 2011-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $185M | $156M | $213M | $184M | $89M | $98M | $57M | $42M | $38M | $39M | $39M | $11M | $21M | $31M | ($2M) | $19M |
| Capital Expenditures (CapEx) | $32M | $35M | $41M | $38M | $24M | $27M | $34M | $42M | $47M | $35M | $21M | $16M | $20M | $18M | $25M | $11M |
| Free Cash Flow (FCF) | $153M | $121M | $172M | $145M | $65M | $71M | $23M | $0M | ($9M) | $4M | $17M | ($5M) | $1M | $13M | ($27M) | $8M |
| FCF Margin % | 20.9% | 16.8% | 23.5% | 22.6% | 13.1% | 16.1% | 6.7% | 0.1% | -2.9% | 1.7% | 6.7% | -2.1% | 0.3% | 5.5% | -13.2% | 7.1% |
| Dividends Paid | — | — | — | $454M | $16M | $16M | $23M | — | $20M | $0M | $10M | $20M | $52M | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | $51M | $48M | $33M | $53M | $36M | $35M | $29M | $60M |
| Capital Expenditures (CapEx) | $9M | $10M | $8M | $5M | $11M | $11M | $12M | $14M |
| Free Cash Flow (FCF) | $43M | $38M | $25M | $47M | $25M | $24M | $17M | $46M |
| FCF Margin % | 23.2% | 22.4% | 13.4% | 24.6% | 14.3% | 14.3% | 8.9% | 24.4% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 | 2014-12-31 | 2013-12-31 | 2012-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $1.7B | $1.6B | $1.6B | $1.5B | $742M | $672M | $631M | $587M | $514M | $455M | $428M | $390M | $389M | $339M | $317M |
| Cash & Cash Equivalents | $224M | $170M | $152M | $144M | $156M | $126M | $93M | $76M | $86M | $66M | $72M | $66M | $68M | $54M | $50M |
| Total Liabilities | $976M | $840M | $845M | $873M | $213M | $226M | $183M | $159M | $149M | $117M | $98M | $95M | $108M | $87M | $84M |
| Total Debt (Short + Long-Term) | $621M | $618M | $609M | $594M | $79M | $80M | $50M | $50M | $50M | $47M | $38M | $41M | $44M | $32M | $38M |
| Total Shareholders' Equity | $768M | $789M | $732M | $639M | $529M | $446M | $402M | $381M | $332M | $337M | $329M | $296M | $282M | $252M | $233M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive AMPH viewer.
About TickerBase · Data methodology & sources · Privacy · Terms